Last reviewed · How we verify
clopidogrel treatment after bare metal stent implantation
At a glance
| Generic name | clopidogrel treatment after bare metal stent implantation |
|---|---|
| Also known as | oral ADP receptor blockers, thienopyridines, Oral ADP receptor blocker |
| Sponsor | Marco Valgimigli |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Dual Antiplatelet Therapy Study (DAPT Study) (PHASE4)
- COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (PHASE4)
- Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PHASE4)
- Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study (PHASE3)
- Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PHASE4)
- Drug Eluting Stent (DES) in Primary Angioplasty (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: